{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:08:20Z","timestamp":1783652900199,"version":"3.55.0"},"reference-count":0,"publisher":"Portico","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2012.48.4.1745225","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T03:40:20Z","timestamp":1406778020000},"page":"283","source":"Crossref","is-referenced-by-count":1,"title":["Utilizing pharmacodynamic properties of second-generation\nantipsychotics to guide treatment"],"prefix":"10.3730","volume":"48","author":[{"family":"Schwartz, T.","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Bedynerman, K.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1320","published-online":{"date-parts":[[2012]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:23:26Z","timestamp":1685453006000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dd4zkk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2012.48.4.1745225","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}